Back
Penumbra Vs. NovoCure Industry Stock Comparison
Buy
69
PEN
Penumbra
Last Price:
245.73
Seasonality Move:
11.06%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Buy
69
Penumbra (PEN)
is a Buy
Is Penumbra a Buy, Sell or Hold?
- The current Penumbra [PEN] share price is $245.55. The Score for PEN is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- PEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PEN Stock Price Chart
PEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.56 | Buy |
| Relative Strength Index (14 RSI): | 56.43 | Buy |
| Chaikin Money Flow: | -163159 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (237.32 - 247.46) | Buy |
| Bollinger Bands (100): | (183.99 - 232.17) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.78 | Buy |
| Relative Strength Index (14 RSI): | 75.34 | Buy |
| Chaikin Money Flow: | 1118573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.36 - 28.56) | Buy |
| Bollinger Bands (100): | (14.7 - 22.78) | Buy |
PEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 245.45 | Buy |
| 20-day SMA: | 243.78 | Buy |
| 50-day SMA: | 226.17 | Buy |
| 200-day SMA: | 206.53 | Buy |
| 8-day EMA: | 246.32 | Sell |
| 20-day EMA: | 242.27 | Buy |
| 50-day EMA: | 229.54 | Buy |
| 200-day EMA: | 215.79 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Buy |
| 20-day SMA: | 23.68 | Buy |
| 50-day SMA: | 19.33 | Buy |
| 200-day SMA: | 17.9 | Buy |
| 8-day EMA: | 29.53 | Buy |
| 20-day EMA: | 25.45 | Buy |
| 50-day EMA: | 21.38 | Buy |
| 200-day EMA: | 19.88 | Buy |
Penumbra Earnings Growth & PEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $1.02 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Penumbra Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||